Micronics (Molecular diagnostic) Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Mezzanine

  • Latest Deal Amount
  • $24M

  • Investors
  • 2

Micronics (Molecular diagnostic) General Information

Description

Developer of medical point-of-care devices designed to offer timely and accurate diagnosis and provide essential information for patients. The company develops near-patient, point-of-care devices for disease diagnosis, treatment monitoring and blood testing, and provides custom design and development services that range from prototype to commercial development of disposable cartridges and integrated cartridge/instrument systems and system integration services, including instrument development, enabling patients with accurate diagnosis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 8463 154th Avenue Northeast
  • Building G
  • Redmond, WA 98052
  • United States
+1 (425)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Services
Corporate Office
  • 8463 154th Avenue Northeast
  • Building G
  • Redmond, WA 98052
  • United States
+1 (425)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Micronics (Molecular diagnostic) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Mezzanine 28-Mar-2013 $24M Completed Generating Revenue
8. Merger/Acquisition 27-Sep-2011 Completed Generating Revenue
7. Later Stage VC (Series C3) 14-Jan-2010 Completed Generating Revenue
6. Later Stage VC (Series C) 16-Oct-2008 Completed Generating Revenue
5. Later Stage VC (Series B) 12-Feb-2008 Completed Generating Revenue
4. Later Stage VC (Series A) 21-Oct-2002 Completed Product Development
3. Seed Round 30-Jan-2000 Completed Product Development
2. Accelerator/Incubator Completed Product Development
1. University Spin-Out 01-Jan-1996 Completed Startup
To view Micronics (Molecular diagnostic)’s complete valuation and funding history, request access »

Micronics (Molecular diagnostic) Patents

Micronics (Molecular diagnostic) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250387735-A1 Filter assembly for a filter press Pending 25-Jun-2024
WO-2026006380-A1 Filter assembly for a filter press Pending 25-Jun-2024
WO-2017143120-A1 Microfluidic mixing device and method Inactive 19-Feb-2016
WO-2016176613-A1 Specimen collection and delivery apparatus Inactive 29-Apr-2015
WO-2015191916-A1 Microfluidic cartridges and apparatus with integrated assay controls for analysis of nucleic acids Inactive 11-Jun-2014 B01L3/50273
To view Micronics (Molecular diagnostic)’s complete patent history, request access »

Micronics (Molecular diagnostic) Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ardesta Venture Capital Minority
Open Prairie Ventures Asset Manager Minority
Pall Corporation Minority
RC Capital (Cincinnati) Growth/Expansion Minority
Sentron Medical Corporation Minority
You’re viewing 5 of 8 investors. Get the full list »

Micronics (Molecular diagnostic) FAQs

  • When was Micronics (Molecular diagnostic) founded?

    Micronics (Molecular diagnostic) was founded in 1996.

  • Where is Micronics (Molecular diagnostic) headquartered?

    Micronics (Molecular diagnostic) is headquartered in Redmond, WA.

  • What industry is Micronics (Molecular diagnostic) in?

    Micronics (Molecular diagnostic)’s primary industry is Diagnostic Equipment.

  • Is Micronics (Molecular diagnostic) a private or public company?

    Micronics (Molecular diagnostic) is a Private company.

  • What is Micronics (Molecular diagnostic)’s current revenue?

    The current revenue for Micronics (Molecular diagnostic) is .

  • How much funding has Micronics (Molecular diagnostic) raised over time?

    Micronics (Molecular diagnostic) has raised $24M.

  • Who are Micronics (Molecular diagnostic)’s investors?

    Ardesta, Open Prairie Ventures, Pall, RC Capital (Cincinnati), and Sentron Medical are 5 of 8 investors who have invested in Micronics (Molecular diagnostic).

  • When was Micronics (Molecular diagnostic) acquired?

    Micronics (Molecular diagnostic) was acquired on 28-Mar-2013.

  • Who acquired Micronics (Molecular diagnostic)?

    Micronics (Molecular diagnostic) was acquired by Sony Corporation of America.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process